Literature DB >> 29981443

The role of nuclear matrix protein HNRNPU in maintaining the architecture of 3D genome.

Linlin Zhang1, Dongli Song1, Bijun Zhu1, Xiangdong Wang2.   

Abstract

The complexity of higher eukaryote genomes is far from being explained by linear information. There is a need to understand roles of genome regulation at the organism level through defining a comprehensive profile of chromosomal organization. Chromosome conformation capture (3C)-based studies reveal that higher-order of chromatin include not only long-range chromatin loops, but also compartments and topologically associating domains as the basis of genome structure and functions. However, the molecular machinery how the genome is spatially organized is still inadequate. Exciting progress has been made with the development of today's technology, we find that heterogeneous nuclear ribonucleoprotein U, initially identified as a structural nuclear protein, plays important role in three-dimensional (3D) genome organization by high-throughput assays. The disruption of this protein not only results in compartment switching on of the genome, it also reduces of TAD boundary strengths at borders between two types of compartments, and regulates chromatin loop by decrease its intensities. In addition, HNRNPU mainly binds to active chromatin. Most of HNRNPU peaks is consistent with CTCF or RAD21.It also plays an irreplaceable role in the processes of mitosis. This review aims to discuss the role of HNRNPU in maintaining the 3D chromatin architecture, as well as the recent development and human diseases involved in this nuclear matrix (NM)-associated protein.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Chromatin loop; Compartment; HNRNPU; Mitosis; Transcription

Mesh:

Substances:

Year:  2018        PMID: 29981443     DOI: 10.1016/j.semcdb.2018.07.006

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  6 in total

1.  O-GlcNAcylation of Thr12/Ser56 in short-form O-GlcNAc transferase (sOGT) regulates its substrate selectivity.

Authors:  Li Liu; Ling Li; Cheng Ma; Yangde Shi; Congcong Liu; Zikang Xiao; Yong Zhang; Fang Tian; Yang Gao; Jie Zhang; Wantao Ying; Peng George Wang; Lianwen Zhang
Journal:  J Biol Chem       Date:  2019-09-16       Impact factor: 5.157

2.  Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications.

Authors:  Aida Barreiro-Alonso; María Cámara-Quílez; Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; Olaia Martínez-Iglesias; Angélica Figueroa; María-Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

3.  Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases.

Authors:  Zsófia Gál; András Gézsi; Ágnes F Semsei; Adrienne Nagy; Monika Sultész; Zsuzsanna Csoma; Lilla Tamási; Gabriella Gálffy; Csaba Szalai
Journal:  J Transl Med       Date:  2020-11-10       Impact factor: 5.531

4.  The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal Adenocarcinoma.

Authors:  Yixin Li; Hui Wang; Jiajia Wan; Qian Ma; Yu Qi; Zhuoyu Gu
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

Review 5.  RNA-binding proteins in tumor progression.

Authors:  Hai Qin; Haiwei Ni; Yichen Liu; Yaqin Yuan; Tao Xi; Xiaoman Li; Lufeng Zheng
Journal:  J Hematol Oncol       Date:  2020-07-11       Impact factor: 17.388

6.  HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.

Authors:  Huajie Song; Dan Li; Xiaojing Wang; Erhu Fang; Feng Yang; Anpei Hu; Jianqun Wang; Yanhua Guo; Yang Liu; Hongjun Li; Yajun Chen; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  J Hematol Oncol       Date:  2020-03-26       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.